Is pemigatinib available in the country? How much

In March 2022, Pemigatinib (Pemigatinib) The original drug has been approved by the National Medical Products Administration for marketing in China. It is suitable for the treatment of previously treated, unresectable locally advanced or metastatic cholangiocarcinoma and associated with fibroblast growth factor receptor1 (FGFR1) rearrangement Recurrent or refractory myeloid/lymphoid tumors have not yet entered the scope of medical insurance due to their short time on the market. They are sold under the trade name of Dabotan. The price of 4.5mg*14 tablets per box may be around 30,000 yuan, and the price of 9mg*14 tablets per box may be around 50,000 yuan. The expensive price may increase the financial burden of some families. Currently, there is no domestically produced pemetinib in China.